E.M. Miller
Montefiore Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by E.M. Miller.
Gynecologic Oncology | 2018
Amerigo Rossi; Laena Frechette; Devin Miller; E.M. Miller; Ciaran P. Friel; Anne Van Arsdale; Juan Lin; Viswanathan Shankar; D.Y.S. Kuo; N.S. Nevadunsky
OBJECTIVE Endometrial cancer survivors are the least physically active of all cancer survivor groups and exhibit up to 70% obesity. While studies suggest lifestyle interventions result in improved health outcomes, recruitment and availability of these programs are limited. The purpose was to evaluate the acceptability and validity of the Fitbit Alta™ physical activity monitor (Fitbit) for socioculturally diverse endometrial cancer survivors. METHODS Thirty endometrial cancer survivors were given wrist-worn Fitbits to wear for 30 days. Participants then returned the Fitbits, completed the Godin Leisure-Time Exercise Questionnaire (GLTEQ), Technology Acceptance Questionnaire, and answered qualitative prompts. Correlations between daily Fitbit step counts, demographic factors, body mass index (BMI), and GLTEQ Index, were analyzed using Stata 13.0. Concordance Correlation Coefficient using U statistics was used to examine convergent validity. RESULTS Twenty-five participants completed the study. Mean age was 62 ± 9 years. Mean BMI was 32 ± 9 kg·m-2. Self-identified race/ethnicity was 36% Hispanic, 36% non-Hispanic white, 16% non-Hispanic black and 12% Asian. Participants wore the Fitbits a median of 93% of possible days. Median daily Fitbit step count was 5325 (IQR: 3761-8753). Mean Technology Acceptance score was 2.8 ± 0.5 out of 4.0. Younger (<65 years) and employed participants were more likely to achieve at least 6000 daily steps (p < 0.05). There was no correlation (CCC = 0.00, p = 0.99) between step count and GLTEQ Index. Most free responses reflected positive experiences. CONCLUSIONS The Fitbits were well accepted in this sample. Self-reported physical activity was not associated with steps recorded. The physical activity data indicate an insufficiently active population.
Journal of Clinical Oncology | 2018
Joan Tymon-Rosario; E.M. Miller; Gregory M. Gressel; Nicole Suzanne Nevadunsky
Journal of Clinical Oncology | 2018
Shayan M Dioun; E.M. Miller; Jennifer Jorgensen; Joan Tymon-Rosario; Xianhong Xie; Xiaonan Xue; Dennis Yi-Shin Kuo; Nicole Suzanne Nevadunsky
Gynecologic Oncology | 2018
L. Frechette; D.T. Miller; Amerigo Rossi; E.M. Miller; A.R. Van Arsdale; Shankar Viswanathan; Nicole Suzanne Nevadunsky
Journal of Clinical Oncology | 2017
E.M. Miller; Joan Tymon-Rosario; Xianhong Xie; Harriet Olivia Smith; Gary L. Goldberg; Dennis Yi-Shin Kuo; Nicole Suzanne Nevadunsky
Journal of Clinical Oncology | 2017
S.M. Dioun; E.M. Miller; Joan Tymon-Rosario; Dennis Yi-Shin Kuo; Nicole Suzanne Nevadunsky
Journal of Clinical Oncology | 2017
E.M. Miller; Amerigo Rossi; David Samuel; Carolina Ramirez; Shankar Viswanathan; Dennis Yi-Shin Kuo; Nicole Suzanne Nevadunsky
Journal of Clinical Oncology | 2017
E.M. Miller; Nicole Patterson; Rouzan G. Karabakhtsian; Michal Bejerano-Sagie; Nivi Ravi; Alexander Y. Maslov; Wilber Quispe-Tintaya; Tao Wang; Juan Lin; Harriet Olivia Smith; Dennis Yi-Shin Kuo; Gary L. Goldberg; Cristina Montagna
Gynecologic Oncology | 2017
N.M. Acosta; E.M. Miller; Shankar Viswanathan; V. Hastings; Gary L. Goldberg; Dennis Yi-Shin Kuo; Marina Frimer
Gynecologic Oncology | 2017
E.M. Miller; Shankar Viswanathan; S. Li; Keyur J. Mehta; Harriet O. Smith; D. Smotkin; Dennis Yi-Shin Kuo; Gary L. Goldberg; Mark H. Einstein; Marina Frimer